Loss of vascular homeostasis is a major contributor to the morbidity and mortality of diabetes, and treatments that restore or prevent loss of vascular homeostasis would be of immense value to diabetic patients. However, the processes leading to loss of vascular homeostasis are poorly understood, and effective treatments are not available. The long term goal is to better understand mechanisms underlying the loss of vascular homeostasis in diabetes in order to develop preventive and therapeutic protocols. Dysregulation of the 268 proteasome has been implicated in the loss of vascular homeostasis in diabetes. It appears to involve enhanced 268 proteasome functionality resulting in down regulation of nitric oxide (NO). The preliminary data suggests that NO itself regulates 268 proteasomes, a mechanism that might be compromised in diabetes. Therefore, the objective in this application is to identify how NO regulates 268 proteasomes. The central hypothesis is that eNOS-derived homeostatic levels of nitric oxide, via maintaining the 0-GlcNAc modification of the regulatory complex PA700 (Rpt2), functions as an endogenous inhibitor of 268 proteasomes to preserve vascular homeostasis, which is lost in diabetes. The rationale for the proposed research is that the identified mechanism may help to understand how vascular homeostasis is lost in patients of diabetes, epidemic of which is believed to hit half of this country by 2020. Guided by strong preliminary data, the hypothesis will be tested by pursuing two specific aims: 1) Determine if endothelial NO inhibits 268 proteasome functionality via maintaining 0-GlcNAc modification of the regulatory complex PA700 (Rpt2);and 2): Determine if pharmacologic or genetic strategies that restore eNOS-derived NO or enhance PA700 (Rpt2) 0-GlcNAc modification suppress 268 proteasome functionality and mitigate endothelial dysfunction in diabetes. The approach is innovative, because it utilizes a proteasome reporter system to study diabetic vascular endothelial function. The proposed research is also significant, because it is expected to provide insight into therapeutic interventions in addition to fundamentally advancing the fields of vascular medicine.
The proposed research is relevant to public health, because the discovery of NO-mediated 268 proteasome regulation in the prevention of endothelial dysfunction.is expected to improve understanding of the pathogenesis of vascular homeostasis loss in diabetes. It also bears the hope of developing better preventive and therapeutic protocols to this common abnormality in people with diabetes.
|Chen, Qian; Qiu, Fangfang; Zhou, Kelu et al. (2017) Pathogenic Role of microRNA-21 in Diabetic Retinopathy Through Downregulation of PPAR?. Diabetes 66:1671-1682|
|Li, Manna; Qian, Ming; Xu, Jian (2017) Vascular Endothelial Regulation of Obesity-Associated Insulin Resistance. Front Cardiovasc Med 4:51|
|Pearsall, Elizabeth A; Cheng, Rui; Zhou, Kelu et al. (2017) PPAR? is essential for retinal lipid metabolism and neuronal survival. BMC Biol 15:113|
|Vadvalkar, Shraddha S; Matsuzaki, Satoshi; Eyster, Craig A et al. (2017) Decreased Mitochondrial Pyruvate Transport Activity in the Diabetic Heart: ROLE OF MITOCHONDRIAL PYRUVATE CARRIER 2 (MPC2) ACETYLATION. J Biol Chem 292:4423-4433|
|Le, Yun-Zheng (2017) VEGF production and signaling in Müller glia are critical to modulating vascular function and neuronal integrity in diabetic retinopathy and hypoxic retinal vascular diseases. Vision Res 139:108-114|
|Qiu, Fangfang; Liu, Zhen; Zhou, Yueping et al. (2017) Decreased Circulating Levels of Dickkopf-1 in Patients with Exudative Age-related Macular Degeneration. Sci Rep 7:1263|
|He, Xuemin; Cheng, Rui; Park, Kyoungmin et al. (2017) Pigment epithelium-derived factor, a noninhibitory serine protease inhibitor, is renoprotective by inhibiting the Wnt pathway. Kidney Int 91:642-657|
|Jung, Dongju; Xu, Yuechi; Sun, Zhongjie (2017) Induction of anti-aging gene klotho with a small chemical compound that demethylates CpG islands. Oncotarget 8:46745-46755|
|Du, Mei; Phelps, Eric; Balangue, Michael J et al. (2017) Transgenic Mice Over-Expressing RBP4 Have RBP4-Dependent and Light-Independent Retinal Degeneration. Invest Ophthalmol Vis Sci 58:4375–4383|
|Shin, Younghwa; Moiseyev, Gennadiy; Chakraborty, Dibyendu et al. (2017) A Dominant Mutation in Rpe65, D477G, Delays Dark Adaptation and Disturbs the Visual Cycle in the Mutant Knock-In Mice. Am J Pathol 187:517-527|
Showing the most recent 10 out of 94 publications